Boehringer Ingelheim Animal Health Denmark A/S — Credit Rating and Financial Key Figures

Boehringer Ingelheim Animal Health Denmark A/S (CVR number: 13526990) is a company from KØBENHAVN. The company reported a net sales of 634.4 mDKK in 2024, demonstrating a growth of 8.4 % compared to the previous year. The operating profit percentage was at 9.9 % (EBIT: 62.7 mDKK), while net earnings were 40.4 mDKK. The profitability of the company measured by Return on Assets (ROA) was 16.7 %, which can be considered excellent and Return on Equity (ROE) was 38.1 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 28.1 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. Boehringer Ingelheim Animal Health Denmark A/S's liquidity measured by quick ratio was 0.6 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.